Broad Spectrum Antiviral Therapy can Supersede Vaccination Strategy for Combating COVID19 Pandemic

Authors: Diwan A , Chakraborty A* , Tatake J , Barton R , Chiniga V , Pandey R , Holkar P , Arora V , Thakur Y , Holkar N and Pond B

DOI: 10.23880/mjccs-16000298

Volume 5, Issue 4

Abstract

As of today seven coronaviruses were identified to infect humans, out of which only 4 of them belongs to beta family of coronavirus, like HCoV-HKU1, SARS-CoV-2, MERS-CoV and SARS-CoV. SARS family viruses were known to cause severe respiratory disease in humans. SARS-CoV-2 has recently considered as a pandemic with over 100 M confirmed cases and over 1.5 M death worldwide. Vaccines and antibodies appeared as record pace. However, generation of variants has already been demonstrated as an escape of virus from a particular vaccine therapy. Therefore, a broad-spectrum anti-CoV therapies should be emphasized.

Keywords: COVID-19; SARS-CoV-2; Therapy; Vaccine; Antibodies; Plasma Therapy; Antiviral; Remdesivir; Chloroquine/ Hydroxychloroquine; Nanoviricides; Venus-Flytrap

View PDF